Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ED Treatment of Suicidal Patients With Ketamine Infusion

NCT03502551 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT03502551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03502551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ED Treatment of Suicidal Patients With Ketamine Infusion
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Withdrawn
Start date
April 1, 2019
Completion date
June 30, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation, suicide